Increased CD13 Expression Reduces Reactive Oxygen Species, Promoting Survival of Liver Cancer Stem Cells via an Epithelial–Mesenchymal Transition-like Phenomenon

被引：0
|
作者：
Ho Min Kim
Naotsugu Haraguchi
Hideshi Ishii
Masahisa Ohkuma
Miho Okano
Koshi Mimori
Hidetoshi Eguchi
Hirofumi Yamamoto
Hiroaki Nagano
Mitsugu Sekimoto
Yuichiro Doki
Masaki Mori
机构：
[1] Osaka University Graduate School of Medicine,Department of Gastroenterological Surgery
[2] Kyushu University,Department of Molecular and Cellular Biology, Division of Molecular and Surgical Oncology
[3] Medical Institute of Bioregulation,Department of Gastroenterological Surgery
[4] Jikei Collage Graduate School of Medicine,undefined
来源：
Annals of Surgical Oncology | 2012年 / 19卷
关键词：
Tace; Reactive Oxygen Species Level; Intracellular Reactive Oxygen Species; Liver Cancer Cell; Intracellular Reactive Oxygen Species Level;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：539 / 548
页数：9
相关论文
共 50 条
  • [1] Increased CD13 Expression Reduces Reactive Oxygen Species, Promoting Survival of Liver Cancer Stem Cells via an Epithelial-Mesenchymal Transition-like Phenomenon
    Kim, Ho Min
    Haraguchi, Naotsugu
    Ishii, Hideshi
    Ohkuma, Masahisa
    Okano, Miho
    Mimori, Koshi
    Eguchi, Hidetoshi
    Yamamoto, Hirofumi
    Nagano, Hiroaki
    Sekimoto, Mitsugu
    Doki, Yuichiro
    Mori, Masaki
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S539 - S548
  • [2] Helicobacter pylori generates cells with cancer stem cell properties via epithelial–mesenchymal transition-like changes
    E Bessède
    C Staedel
    L A Acuña Amador
    P H Nguyen
    L Chambonnier
    M Hatakeyama
    G Belleannée
    F Mégraud
    C Varon
    Oncogene, 2014, 33 : 4123 - 4131
  • [3] Reactive Oxigen Species Produced by Uva Causes Epithelial-Mesenchymal Transition-Like Changes in Corneal Epithelial Cells
    Kato, N.
    Shimmura, S.
    Kawakita, T.
    Miyashita, H.
    Yoshida, S.
    Tsubota, K.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [4] Helicobacter pylori generates cells with cancer stem cell properties via epithelial-mesenchymal transition-like changes
    Bessede, E.
    Staedel, C.
    Amador, L. A. Acuna
    Nguyen, P. H.
    Chambonnier, L.
    Hatakeyama, M.
    Belleannee, G.
    Megraud, F.
    Varon, C.
    ONCOGENE, 2014, 33 (32) : 4123 - 4131
  • [5] Expression of embryonic liver fodrin (ELF) and stem cell markers in CD13 liver cancer stem cells
    Yu, G.
    Wen, Q.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (06) : 1653 - 1657
  • [6] Tumor budding of cervical squamous cell carcinoma: epithelial-mesenchymal transition-like cancer stem cells?
    Zheng, Shaoqiu
    Luo, Jing
    Xie, Shoucheng
    Lu, Shanming
    Liu, Qinghua
    Xiao, Huanqin
    Luo, Wenjuan
    Huang, Yanfang
    Liu, Kun
    PEERJ, 2022, 10
  • [7] Elevated level of mitochondrial reactive oxygen species via fatty acid β-oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial–mesenchymal transition
    Caihua Wang
    Liming Shao
    Chi Pan
    Jun Ye
    Zonghui Ding
    Jia Wu
    Qin Du
    Yuezhong Ren
    Chunpeng Zhu
    Stem Cell Research & Therapy, 10
  • [8] Signaling Mechanism(S) of Reactive Oxygen Species in Epithelial-Mesenchymal Transition Reminiscent of Cancer Stem Cells in Tumor Progression
    Wang, Zhiwei
    Li, Yiwei
    Sarkar, Fazlul H.
    CURRENT STEM CELL RESEARCH & THERAPY, 2010, 5 (01) : 74 - 80
  • [9] Elevated level of mitochondrial reactive oxygen species via fatty acid -oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial-mesenchymal transition
    Wang, Caihua
    Shao, Liming
    Pan, Chi
    Ye, Jun
    Ding, Zonghui
    Wu, Jia
    Du, Qin
    Ren, Yuezhong
    Zhu, Chunpeng
    STEM CELL RESEARCH & THERAPY, 2019, 10 (1)
  • [10] Depletion of mitochondrial reactive oxygen species downregulates epithelial-to-mesenchymal transition in cervical cancer cells
    Shagieva, Galina
    Domnina, Lidiya
    Makarevich, Olga
    Chernyak, Boris
    Skulachev, Vladimir
    Dugina, Vera
    ONCOTARGET, 2017, 8 (03) : 4901 - 4913
12345